AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)
CUSIP: 03152W109
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 312,579,912
- Total 13F shares
- 301,421,729
- Share change
- +7,651,038
- Total reported value
- $3,479,958,222
- Put/Call ratio
- 39%
- Price per share
- $11.55
- Number of holders
- 215
- Value change
- +$96,361,873
- Number of buys
- 87
- Number of sells
- 115
Quarterly Holders Quick Answers
What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03152W109:
Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
8.5%
|
26,559,443
|
$253,643,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.8%
|
24,488,601
|
$233,866,000 | — | 30 Sep 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
7.8%
|
24,295,698
|
$232,024,000 | — | 30 Sep 2021 | |
| Redmile Group, LLC |
13F
|
Company |
6.7%
|
20,799,303
|
$198,633,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.3%
|
19,586,198
|
$187,047,000 | — | 30 Sep 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
5.7%
|
17,679,273
|
$168,837,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.9%
|
15,283,058
|
$145,954,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
3.7%
|
11,688,387
|
$111,624,000 | — | 30 Sep 2021 | |
| Palo Alto Investors LP |
13F
|
Company |
3.2%
|
10,114,043
|
$96,589,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
10,015,730
|
$95,650,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
2.3%
|
7,117,394
|
$67,971,000 | — | 30 Sep 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.3%
|
7,054,208
|
$67,378,000 | — | 30 Sep 2021 | |
| Artal Group S.A. |
13F
|
Company |
2.1%
|
6,696,955
|
$63,956,000 | — | 30 Sep 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2%
|
6,366,584
|
$60,801,000 | — | 30 Sep 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.8%
|
5,671,041
|
$54,158,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
4,450,822
|
$42,505,000 | — | 30 Sep 2021 | |
| Fiera Capital Corp |
13F
|
Company |
0.98%
|
3,064,607
|
$29,267,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.92%
|
2,874,394
|
$27,450,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.91%
|
2,831,000
|
$27,036,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.89%
|
2,777,248
|
$26,523,000 | — | 30 Sep 2021 | |
| NORGES BANK |
13F
|
Company |
0.88%
|
2,762,681
|
$26,384,000 | — | 30 Sep 2021 | |
| Novo Holdings A/S |
13F
|
Company |
0.82%
|
2,560,211
|
$24,450,000 | — | 30 Sep 2021 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.77%
|
2,410,604
|
$23,021,000 | — | 30 Sep 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
0.74%
|
2,325,000
|
$22,204,000 | — | 30 Sep 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.7%
|
2,192,017
|
$20,934,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.68%
|
2,127,755
|
$20,320,000 | — | 30 Sep 2021 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
1,974,972
|
$18,861,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.52%
|
1,625,472
|
$17,881,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
1,870,933
|
$17,868,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.58%
|
1,813,054
|
$17,315,000 | — | 30 Sep 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.58%
|
1,809,792
|
$17,284,000 | — | 30 Sep 2021 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.55%
|
1,714,731
|
$16,376,000 | — | 30 Sep 2021 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.52%
|
1,626,100
|
$15,529,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
0.42%
|
1,304,101
|
$12,454,000 | — | 30 Sep 2021 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.4%
|
1,261,163
|
$12,044,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.36%
|
1,119,878
|
$10,695,000 | — | 30 Sep 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.36%
|
1,109,969
|
$10,600,000 | — | 30 Sep 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.32%
|
1,012,506
|
$9,669,000 | — | 30 Sep 2021 | |
| Grosvenor Holdings, L.L.C. |
13F
|
Company |
0.31%
|
964,704
|
$9,213,000 | — | 30 Sep 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.29%
|
915,524
|
$8,743,000 | — | 30 Sep 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.28%
|
886,513
|
$8,466,000 | — | 30 Sep 2021 | |
| BROOKFIELD Corp /ON/ |
13F
|
Company |
0.27%
|
845,000
|
$8,070,000 | — | 30 Sep 2021 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.25%
|
782,015
|
$7,469,000 | — | 30 Sep 2021 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.24%
|
743,546
|
$7,350,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.24%
|
750,892
|
$7,171,000 | — | 30 Sep 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.24%
|
738,648
|
$7,054,000 | — | 30 Sep 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.23%
|
731,906
|
$6,990,000 | — | 30 Sep 2021 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.23%
|
709,852
|
$6,779,000 | — | 30 Sep 2021 | |
| Asymmetry Capital Management, L.P. |
13F
|
Company |
0.21%
|
653,976
|
$6,245,000 | — | 30 Sep 2021 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.21%
|
646,898
|
$6,178,000 | — | 30 Sep 2021 |
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2021
As of 31 Dec 2021,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
215 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
301,421,729 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, Redmile Group, LLC, BlackRock Inc., Avoro Capital Advisors LLC, JPMORGAN CHASE & CO, MORGAN STANLEY, STATE STREET CORP, and Palo Alto Investors LP.
This page lists
215
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
223
Q4 2021 holders
215
Holder diff
-8
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.